Stem cell transplant numbers decline; research continues.
Stem cell transplant numbers decline; research continues.
复制标题
干细胞移植数量下降；
DOI：
10.1093/jnci/92.24.1972
复制
发表时间：
2000
期刊：
影响因子：
--
通讯作者：
R. Twombly
中科院分区：
文献类型：
--
作者：
R. Twombly
这是一个下坡下降玛丽霍洛维茨，医学博士，从来没有见过。每年，她作为国际骨髓移植登记处的科学主任准备的幻灯片都显示，越来越多的人使用高剂量化疗和干细胞支持。然而，1999年的数字却急剧下降，在1998年北美有7,800例自体移植的高峰之后，1999年只有6,100例（基于志愿者）被报告给IBMTR，IBMTR位于密尔沃基的威斯康星州医学院。在1，700例病例中，除了100例之外，所有病例都是由于减少了乳腺癌高剂量化疗和自体移植的使用，传统上占手术的近一半。
It is a downhill descent Mary Horowitz, MD, has never seen. Every year, the slides she has prepared as scientific director of the International Bone Marrow Transplant Registry have shown increasing use of high-dose chemotherapy and stem cell support. The numbers just in for 1999, however, point precipitously downward.After a high of 7,800 autotransplants in North America in 1998, only 6,100 were reported (on a volunteer basis) in 1999 to the IBMTR, which is housed at the Medical College of Wisconsin, Milwaukee. Of the 1,700 drop in cases, all except 100 are due to reduced use of high-dose chemotherapy and autotransplants in breast cancer, which has traditionally accounted for almost half of the procedures.